The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - Karyopharm Therapeutics
Stock and Other Ownership Interests - Karyopharm Therapeutics
Consulting or Advisory Role - AstraZeneca/Merck; BIOCAD; GlaxoSmithKline; Karyopharm Therapeutics; Merck; Roche; Zai Lab
Speakers' Bureau - AstraZeneca/Merck; GlaxoSmithKline
Research Funding - Apexigen (Inst); AstraZeneca/Merck (Inst); Deciphera (Inst); GlaxoSmithKline (Inst); Ultimovacs (Inst)
 
Consulting or Advisory Role - AZD; GlaxoSmithKline; Merck
Speakers' Bureau - AZD; Clovis Oncology; GlaxoSmithKline
Research Funding - Merck (Inst)
Travel, Accommodations, Expenses - AZD; GlaxoSmithKline

Dostarlimab in advanced/recurrent (AR) mismatch repair deficient/microsatellite instability–high or proficient/stable (dMMR/MSI-H or MMRp/MSS) endometrial cancer (EC): The GARNET study.
 
Ana Oaknin
Consulting or Advisory Role - AGENUS; Amgen; AstraZeneca; Clovis Oncology; Corcept Therapeutics; Deciphera; Eisai; EMD Serono; Genmab; GlaxoSmithKline; Immunogen; ITeos Therapeutics; Medison; Merck Sharp & Dohme; Mersana; Novocure; PharmaMar; prIME Oncology; Roche; Roche; Shattuck Labs; Sutro Biopharma; Tesaro
Research Funding - Abbvie (Inst); Ability Pharma (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Agenus (Inst); Aprea Therapeutics (Inst); AstraZeneca (Inst); BeiGene (Inst); Belgian Gynaecological Oncology Group (Inst); Bristol-Myers Squibb International Corporation (BMS) (Inst); Clovis Oncology (Inst); Corcept Therapeutics (Inst); Eisai (Inst); Immunogen (Inst); Iovance Biotherapeutics (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Medimmune (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Mundipharma Research (Inst); Novartis Farmacéutica (Inst); Regeneron (Inst); Roche (Inst); Seagen (Inst); Seagen (Inst); Sutro Biopharma (Inst); Tesaro (Inst); Verastem (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; PharmaMar; Roche
 
Bhavana Pothuri
Consulting or Advisory Role - AstraZeneca; BioAscent; Clovis Oncology; Curio Science; Department of Defense; Eisai; Elevar Therapeutics; GlaxoSmithKline; Intuitive Surgical; McGivney Global Advisors; Merck; Mersana; Rubin, Paterniti, Gonzalez LLC; Tesaro; Toray Industries; Vaniam Group
Research Funding - AstraZeneca (Inst); Celgene (Inst); Celsion (Inst); Clovis Oncology (Inst); Genentech (Inst); Immunogen (Inst); Merck (Inst); Takeda (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Eisai; Tesaro
 
Lucy Gilbert
Honoraria - AstraZeneca; Eisai; GlaxoSmithKline; Merck; Merck/Eisai
Consulting or Advisory Role - GlaxoSmithKline; Merck
Research Funding - Alkermes (Inst); AstraZeneca (Inst); Esperas Pharma (Inst); Immunogen (Inst); IMV (Inst); Karyopharm Therapeutics (Inst); Merck Sharp & Dohme (Inst); Mersana (Inst); Novocure (Inst); OncoQuest (Inst); Roche (Inst); Tesaro/GSK (Inst)
 
Renaud Sabatier
Honoraria - AstraZeneca; Clovis Oncology; GlaxoSmithKline; Novartis
Consulting or Advisory Role - GlaxoSmithKline
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; MSD Oncology
 
Sharad A. Ghamande
Consulting or Advisory Role - Seagen
Speakers' Bureau - Eisai; Tesaro/GSK
Research Funding - Abbvie (Inst); Advaxis (Inst); Akeso Biopharma (Inst); Aravive (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Ellipses Pharma (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Jounce Therapeutics (Inst); Merck (Inst); Merck Serono (Inst); Roche (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst)
 
Adriano Gravina
Travel, Accommodations, Expenses - Pfizer
 
Emiliano Calvo
Employment - HM Hospitales; START
Leadership - START
Stock and Other Ownership Interests - Oncoart Associated; START
Honoraria - HM Hospitales
Consulting or Advisory Role - Adcendo; Alkermes; Amcure; Amunix; Anaveon; AstraZeneca/MedImmune; BeiGene; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Janssen-Cilag; MedSIR; MonTa Biosciences; MSD Oncology; Nanobiotix; Nouscom; Novartis; OncoDNA; PharmaMar; PsiOxus Therapeutics; Roche/Genentech; Sanofi; Seagen; Servier; Syneos Health; T-Knife; TargImmune Therapeutics
Research Funding - Achilles Therapeutics (Inst); BeiGene; START
Other Relationship - Investigational Therapeutics in Oncological Sciences
 
Susana N. Banerjee
Honoraria - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; Immunogen; Mersana; MSD Oncology; Pfizer; Roche; Takeda
Consulting or Advisory Role - Amgen; AstraZeneca; GenMab; GlaxoSmithKline; Immunogen; Merck Serono; Mersana; MSD Oncology; OncXerna Therapeutics; Seagen; Shattuck Labs
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst)
 
Rowan Miller
No Relationships to Disclose
 
Joanna Pikiel
Honoraria - Amgen; Clovis Oncology; GlaxoSmithKline; Incyte; Novartis; Odonate Therapeutics; Pfizer; Regeneron; Roche
Travel, Accommodations, Expenses - Roche
 
Mansoor Raza Mirza
No Relationships to Disclose
 
Tao Duan
Employment - GlaxoSmithKline
 
Sybil Zildjian
Employment - GlaxoSmithKline
 
Eleftherios Zografos
Employment - GlaxoSmithKline
 
Jennifer Taylor Veneris
Employment - GlaxoSmithKline
 
Anna Tinker
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca/MedImmune (Inst)
Other Relationship - AstraZeneca
(OPTIONAL) Uncompensated Relationships - GlaxoSmithKline
 
Matthew A. Powell
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; GlaxoSmithKline/Tesaro; GOG partners; Roche/Genentech; Seagen; Tesaro
Research Funding - GlaxoSmithKline/Tesaro (Inst)